Muazzam Nasrullah1, Laura G Wesolowski2, Steven F Ethridge2, Kevin Cranston3, Michael Pentella3, Robert A Myers4, James T Rudrik5, Angela B Hutchinson2, Spencer B Bennett6, Barbara G Werner3. 1. Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: snasrullah@cdc.gov. 2. Division of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. 3. Massachusetts Department of Public Health, Boston, MA, USA. 4. Maryland Department of Health and Mental Hygiene, Baltimore, MD, USA. 5. Michigan Department of Health and Human Services, Lansing, MI, USA. 6. Florida Bureau of Public Health Laboratories, Jacksonville, FL, USA.
Abstract
OBJECTIVE: In three U.S. State Public Health Laboratories (PHLs) using a fourth-generation immunoassay (IA), an HIV-1/HIV-2 differentiation antibody IA and a nucleic acid test (NAT), we characterized the yield and time to reporting of acute infections, and cost per positive specimen. METHODS: Routine HIV testing data were collected from July 1, 2012-June 30, 2013 for Massachusetts and Maryland PHLs, and from November 27, 2012-June 30, 2013 for Michigan PHL. Massachusetts and Michigan used fourth-generation and differentiation IAs with NAT conducted by a referral laboratory. In Maryland, fourth-generation IA repeatedly reactive specimens were followed by a Western blot (WB), and those with negative or indeterminate results were tested with a differentiation IA and HIV-1 NAT, and if positive by NAT, confirmed by a different HIV-1 NAT. Specimens from WB-positive persons at risk for HIV-2 were tested with a differentiation IA and, if positive, with an HIV-2 WB and/or differential HIV-1/HIV-2 proviral DNA polymerase chain reaction. RESULTS: Among 7914 specimens from Massachusetts PHL, 6069 from Michigan PHL, and 36,266 from Maryland PHL, 0.10%, 0.02% and 0.05% acute infections were identified, respectively. Massachusetts and Maryland PHLs each had 1 HIV-2 positive specimen. The median time from specimen receipt to laboratory reporting of results for acute infections at Massachusetts, Michigan and Maryland PHLs was 8, 11, and 7 days respectively. The laboratory cost per HIV positive specimen was $336 (Massachusetts), $263 (Michigan) and $210 (Maryland). CONCLUSIONS: Acute and established infections were found by PHLs using fourth-generation IA in conjunction with antibody tests and NAT. Time to reporting of acute HIV test results to clients was suboptimal, and needs to be streamlined to expedite treatment and interrupt transmission. Published by Elsevier Ltd.
OBJECTIVE: In three U.S. State Public Health Laboratories (PHLs) using a fourth-generation immunoassay (IA), an HIV-1/HIV-2 differentiation antibody IA and a nucleic acid test (NAT), we characterized the yield and time to reporting of acute infections, and cost per positive specimen. METHODS: Routine HIV testing data were collected from July 1, 2012-June 30, 2013 for Massachusetts and Maryland PHLs, and from November 27, 2012-June 30, 2013 for Michigan PHL. Massachusetts and Michigan used fourth-generation and differentiation IAs with NAT conducted by a referral laboratory. In Maryland, fourth-generation IA repeatedly reactive specimens were followed by a Western blot (WB), and those with negative or indeterminate results were tested with a differentiation IA and HIV-1 NAT, and if positive by NAT, confirmed by a different HIV-1 NAT. Specimens from WB-positive persons at risk for HIV-2 were tested with a differentiation IA and, if positive, with an HIV-2 WB and/or differential HIV-1/HIV-2 proviral DNA polymerase chain reaction. RESULTS: Among 7914 specimens from Massachusetts PHL, 6069 from Michigan PHL, and 36,266 from Maryland PHL, 0.10%, 0.02% and 0.05% acute infections were identified, respectively. Massachusetts and Maryland PHLs each had 1 HIV-2 positive specimen. The median time from specimen receipt to laboratory reporting of results for acute infections at Massachusetts, Michigan and Maryland PHLs was 8, 11, and 7 days respectively. The laboratory cost per HIV positive specimen was $336 (Massachusetts), $263 (Michigan) and $210 (Maryland). CONCLUSIONS: Acute and established infections were found by PHLs using fourth-generation IA in conjunction with antibody tests and NAT. Time to reporting of acute HIV test results to clients was suboptimal, and needs to be streamlined to expedite treatment and interrupt transmission. Published by Elsevier Ltd.
Entities:
Keywords:
Acute infections; Cost; Fourth-generation immunoassay; HIV testing algorithms; Time to reporting
Authors: Silvina Masciotra; J Steven McDougal; Jane Feldman; Patrick Sprinkle; Laura Wesolowski; S Michele Owen Journal: J Clin Virol Date: 2011-10-05 Impact factor: 3.168
Authors: Muazzam Nasrullah; Steven F Ethridge; Kevin P Delaney; Laura G Wesolowski; Timothy C Granade; Joe Schwendemann; Robert D Boromisa; James D Heffelfinger; S Michele Owen; Bernard M Branson Journal: J Clin Virol Date: 2011-10-12 Impact factor: 3.168
Authors: Mark W Pandori; John Hackett; Brian Louie; Ana Vallari; Teri Dowling; Sally Liska; Jeffrey D Klausner Journal: J Clin Microbiol Date: 2009-06-17 Impact factor: 5.948
Authors: F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw Journal: J Virol Date: 1994-11 Impact factor: 5.103
Authors: A Mühlbacher; H Schennach; J van Helden; T Hebell; G Pantaleo; P Bürgisser; C Cellerai; P Permpikul; M I Rodriguez; A Eiras; F Alborino; P Cunningham; M Axelsson; S Andersson; O Wetlitzky; C Kaiser; P Möller; G de Sousa Journal: Med Microbiol Immunol Date: 2012-06-17 Impact factor: 3.402
Authors: Karolina Kozaczynska; Marion Cornelissen; Peter Reiss; Fokla Zorgdrager; Antoinette C van der Kuyl Journal: Retrovirology Date: 2007-08-23 Impact factor: 4.602
Authors: Trevor A Crowell; Justin Ritz; Robert W Coombs; Lu Zheng; Joseph J Eron; John W Mellors; Joan Dragavon; Gert U van Zyl; Javier R Lama; Kiat Ruxrungtham; Beatriz Grinsztejn; Roberto C Arduino; Lawrence Fox; Jintanat Ananworanich; Eric S Daar Journal: Clin Infect Dis Date: 2021-08-02 Impact factor: 20.999